Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Rebuffed, Hyseq Remains in Favor in Bid for Variangenics

NEW YORK, Jan. 21 - Hyseq's bid to buy Variagenics is still a go after the attention of another suitor was rebuffed, Variagenics said today.

 

CombiMatrix, owned by Acacia Research Corporation, made an unsolicited merger bid for Variagenics, the company said. The proposal included a stock-for-stock merger.

 

Variagenics board of directors voted down the proposal and reaffirmed their intention of merging with Hyseq, according to the company.

 

Click here for more information.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.